Navigation Links
Johnson & Johnson Reports 2011 Fourth-Quarter and Full-Year Results:
Date:1/24/2012

ines, proteins and antibodies from Crucell that prevent and/or treat infectious diseases; PREZISTA® (darunavir), a treatment for HIV; and VELCADE® (bortezomib), a treatment for multiple myeloma.

During the quarter, the U.S. Food and Drug Administration (FDA) approved an additional indication for XARELTO® (rivaroxaban) to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. In addition, the European Commission granted marketing authorization for EDURANT® (rilpivirine) as a once daily treatment, in combination with other antiretroviral agents (ARVs), for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in ARV treatment-naive adult patients with a viral load < 100,000 HIV-1 RNA copies/mL.

Also during the quarter, supplemental New Drug Applications were submitted to the FDA seeking approval for the use of XARELTO® (rivaroxaban), an oral anticoagulant, to reduce the risk of thrombotic cardiovascular events in patients with Acute Coronary Syndrome, and for NUCYNTA® ER (tapentadol) extended-release tablets, an oral analgesic, for the management of neuropathic pain associated with diabetic peripheral neuropathy in adults. The Company also announced an agreement with Pharmacyclics, Inc. to jointly develop and market the BTK Inhibitor, PCI-32765, for the treatment of cancer.

Worldwide Medical Devices and Diagnostics sales of $25.8 billion for the full-year 2011 represented an increase of 4.8% versus the prior year with an operational increase of 1.7% and a positive impact from currency of 3.1%. Domestic sales decreased 0.4%; international sales increased 9.2%, which reflected an operational increase of 3.4% and a positive currency impact of 5.8%.Primary contributors to operational growth included Ethicon's surgical care products; Ethicon Endo-Surgery's Advanced Sterilization Products and international sales of minimally invasive products; Diabetes Ca
'/>"/>

SOURCE Johnson & Johnson
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine technology :

1. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Societys Annual Meeting
2. Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)
3. Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries
4. Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009
5. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
6. Palomar to Commercialize FDA Cleared Over-The-Counter Home Use Wrinkle Treatment Laser Device Without Johnson & Johnson
7. U.S. Files Suit Against Johnson & Johnson For Paying Kickbacks to Nations Largest Nursing Home Pharmacy
8. EF Johnson Technologies Announces Third Quarter Results
9. Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
10. Johnson & Johnson to Participate in the 30th Annual Cowen and Company Health Care Conference
11. Two Johnson & Johnson Subsidiaries to Pay Over $81 Million to Resolve Allegations of Off-Label Promotion of Topamax
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015  Pharmaceutical ... new drugs and tests, and this is ... instruments that can assist them. This according to ... Information said instruments such as mass spectrometry, ... in the identification of drug targets and ...
(Date:5/28/2015)... , May 28, 2015 ... announced the addition of Jain PharmaBiotech,s new ...  to their offering.       ... or gene silencing involves the use of ... cell, this material is processed into short ...
(Date:5/28/2015)... ( http://maetrics.com ), a leading international consulting firm focused ... conference, "The cost of non-compliance -- How new regulation is ... Zurich . Hosted by Maetrics ... -based team, experts provided insights on the impact ... exclusive local audience. The event was held in conjunction ...
Breaking Medicine Technology:Report: Proteomics Research Market Reaches $1.6 Billion 2Report: Proteomics Research Market Reaches $1.6 Billion 3Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 3Maetrics Hosts Innovative Medical Cluster Event in Switzerland 2
... N.J., Sept. 27 The American Chemical Society, Informex, and ... to partner in hosting the , ACS Careers Virtual Career ... virtual event, to be held November 2 -3, ... scientific society, chose to work with Informex , the ...
... healthcare market research company ... Online Health Video : Understanding Consumption Patterns to ... health video and the impact of this format on ... significantly among U.S. consumers online for prescription drug information ...
Cached Medicine Technology:Announcing the Inaugural ACS Careers' Virtual Career Fair in Conjunction with Informex and C&EN 2Announcing the Inaugural ACS Careers' Virtual Career Fair in Conjunction with Informex and C&EN 3Announcing the Inaugural ACS Careers' Virtual Career Fair in Conjunction with Informex and C&EN 4New Manhattan Research Report Explores the Growing Consumer Demand for Online Health Video and How Pharma Marketers Can Leverage this Format 2
(Date:5/28/2015)... Falls Church, VA (PRWEB) May 28, 2015 ... Roadmap to the 351(k) Application Process, **FDAnews Webinar**, ... p.m. EDT, [http://www.fdanews.com/BiosimilarsApproval , On June ... and expertise of two leading intellectual property attorneys ... the webinar Success Strategies for Biosimilars Approval: A ...
(Date:5/28/2015)... 28, 2015 On Sunday, June 21, ... a team event to honor the strength, passion and ... summer solstice, the duration of this sunrise-to-sunset event symbolizes ... and their caregivers. Participants raise funds and awareness to ... Alzheimer’s Association. , Teams are encouraged to create their ...
(Date:5/28/2015)... 28, 2015 Park Cities Pet Sitter is ... Training class starting Saturday, June 6th at 10:30am. ... 5831 McCommas Blvd in Dallas, with a maximum of six ... for five weeks, with no class being held over the ... $135. , In this Intermediate-to-Advanced level class, dogs will solidify ...
(Date:5/28/2015)... Restricting access to firearms for people ... that more clearly define alcohol misuse should be developed ... research and public policies by the UC Davis Violence ... 30 in the peer-reviewed journal Preventive Medicine , ... alcohol misuse in association with firearm access and use, ...
(Date:5/28/2015)... NJ (PRWEB) May 28, 2015 The Boys ... of $2,500 from Horizon Blue Cross Blue Shield of New ... golfer Natalie Gulbis, the club can receive much more support ... by Acer. , A former Boys & Girls Club member ... in Sacramento, California, Ms. Gulbis has accepted the Horizon Blue ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 3Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 2Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 3Health News:UC Davis Research Finds That Restricting Firearms Access for People who Misuse Alcohol May Prevent Violence 2Health News:UC Davis Research Finds That Restricting Firearms Access for People who Misuse Alcohol May Prevent Violence 3Health News:UC Davis Research Finds That Restricting Firearms Access for People who Misuse Alcohol May Prevent Violence 4Health News:Golf Pro Natalie Gulbis to Chip in with Horizon Blue Cross Blue Shield of New Jersey to Support Boys & Girls Club of Atlantic City 2Health News:Golf Pro Natalie Gulbis to Chip in with Horizon Blue Cross Blue Shield of New Jersey to Support Boys & Girls Club of Atlantic City 3
... spinal fusions, but experts worry about costs and complications, , ... agent that stimulates the creation of new bone as part ... United States, although costs and some complication rates also appear ... , The therapeutic agent, known as bone-morphogenic protein, or BMP, ...
... can cause liver damage, even death, if used improperly , ... Tuesday to lower the maximum dose of over-the-counter acetaminophen -- ... medications. , The advisers, vote followed the release of a ... that severe liver damage and even death can result from ...
... how patients interpret results, researchers say , TUESDAY, June ... cancer appears to offer some benefits to patients, according ... online test among 44 smokers. , "Up until now ... You see a professional genetics counselor, undergo a battery ...
... 30 At the 8th Annual Spirit of Entrepreneurship ... Texas (EFNT) recognized The Beryl Companies, the nation,s leading ... as the North Star 2009 Inductee. This award is ... show the importance of giving back to our community ...
... lead to serious injury , , , CHICAGO, ... of skateboarding. They learn to master their skills of "riding ... College of Foot and Ankle Surgeons (ACFAS), such tricks, while ... ankle injuries. , , Foot and ankle surgeons ...
... , VIENNA, Va., June 30 CEL-SCI Corporation ... immunotherapy company, today announced that it has completed a registered ... million before deducting placement agent fees and estimated offering expenses. ... 24, 2009 when the Company entered into definitive agreements, was ...
Cached Medicine News:Health News:Assessment of Bone Growth Stimulator Is Mixed 2Health News:Assessment of Bone Growth Stimulator Is Mixed 3Health News:FDA Advisers Urge Smaller Doses of Acetaminophen 2Health News:FDA Advisers Urge Smaller Doses of Acetaminophen 3Health News:Online Genetic Testing Appears to Have Benefits 2Health News:Beryl Receives Entrepreneurs Foundation of North Texas North Star Recognition 2Health News:Surgeons Warn: Skateboarding Tough on Feet, Ankles 2Health News:CEL-SCI Completes $5.85 Million Registered Direct Offering 2Health News:CEL-SCI Completes $5.85 Million Registered Direct Offering 3
The full access underbody blanket is positioned on the procedure table before the patient arrives to the room....
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
The ThermoWrap™ enables true normothermia (36.5°C - 37.5°C), induced hypothermia and precise rewarming....
The full body blanket provides coverage to the entire patient....
Medicine Products: